BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

CytoReason

CytoReason logo

Founded
2016
Publications
5

Technologies

AI Companies (Drug Discovery)

CytoReason turns human clinical data into clear biology, to deliver data-driven target discovery and drug development. CytoReason’s access to unmatched proprietary and public data, combined with cutting-edge machine learning technologies, creates our unique biological models of disease, tissue and drug. Using our molecular-level disease models we turn human clinical data into biology, mapping what the cells, genes and proteins are doing in a disease, tissue and treatment environment. This enables us to uncover disease and drug mechanisms of action and turn that biology into clinical edge, by delivering valuable IP in the form of novel targets, indications, combinations and biomarkers.

Become a Member to view additional information about this company

Posts Mentioning This Company

White Papers And Industry Reports